Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Rifaximin 550 MG
Low FODMAP Diet
Locations
1
United States
University of Michigan
Ann Arbor, Michigan, United States
Start Date
February 13, 2018
Primary Completion Date
February 28, 2024
Completion Date
February 28, 2024
Last Updated
April 27, 2025
NCT07481422
NCT05740319
NCT07089420
NCT06866106
NCT05293769
NCT03823742
Lead Sponsor
University of Michigan
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions